A Therapeutic Antibody for Cancer, Derived from Single Human B Cells
Abstract
Some patients with cancer never develop metastasis, and their host response might provide cues for innovative treatment strategies. We previously reported an association between autoantibodies against complement factor H (CFH) and early-stage lung cancer. CFH prevents complement-mediated cytotoxicity (CDC) by inhibiting formation of cell-lytic membrane attack complexes on self-surfaces. In an effort to translate these findings into a biologic therapy for cancer, we isolated and expressed DNA sequences encoding high-affinity human CFH antibodies directly from single, sorted B cells obtained from patients with the antibody. The co-crystal structure of a CFH antibody-target complex shows a conformational change in the target relative to the native structure. This recombinant CFH antibody causes complement activation and release of anaphylatoxins, promotes CDC of tumor cell lines, and inhibits tumor growth in vivo. The isolation of anti-tumor antibodies derived from single human B cells represents an alternative paradigm in antibody drug discovery.
- Authors:
- Publication Date:
- Research Org.:
- Argonne National Laboratory (ANL), Argonne, IL (United States)
- Sponsoring Org.:
- USDOE Office of Science (SC), Basic Energy Sciences (BES); LUNGevity Foundation, the Dept. of Defense; National Institutes of Health (NIH)
- OSTI Identifier:
- 1325319
- Alternate Identifier(s):
- OSTI ID: 1256369
- Grant/Contract Number:
- W-31-109-Eng-38; W81XWH-13-1-0189; UL1TR001117
- Resource Type:
- Published Article
- Journal Name:
- Cell Reports
- Additional Journal Information:
- Journal Name: Cell Reports Journal Volume: 15 Journal Issue: 7; Journal ID: ISSN 2211-1247
- Publisher:
- Elsevier
- Country of Publication:
- Netherlands
- Language:
- English
- Subject:
- 60 APPLIED LIFE SCIENCES
Citation Formats
Bushey, Ryan T., Moody, M. Anthony, Nicely, Nathan L., Haynes, Barton F., Alam, S. Munir, Keir, Stephen T., Bentley, Rex C., Roy Choudhury, Kingshuk, Gottlin, Elizabeth B., Campa, Michael J., Liao, Hua-Xin, and Patz, Jr., Edward F. A Therapeutic Antibody for Cancer, Derived from Single Human B Cells. Netherlands: N. p., 2016.
Web. doi:10.1016/j.celrep.2016.04.038.
Bushey, Ryan T., Moody, M. Anthony, Nicely, Nathan L., Haynes, Barton F., Alam, S. Munir, Keir, Stephen T., Bentley, Rex C., Roy Choudhury, Kingshuk, Gottlin, Elizabeth B., Campa, Michael J., Liao, Hua-Xin, & Patz, Jr., Edward F. A Therapeutic Antibody for Cancer, Derived from Single Human B Cells. Netherlands. https://doi.org/10.1016/j.celrep.2016.04.038
Bushey, Ryan T., Moody, M. Anthony, Nicely, Nathan L., Haynes, Barton F., Alam, S. Munir, Keir, Stephen T., Bentley, Rex C., Roy Choudhury, Kingshuk, Gottlin, Elizabeth B., Campa, Michael J., Liao, Hua-Xin, and Patz, Jr., Edward F. Sun .
"A Therapeutic Antibody for Cancer, Derived from Single Human B Cells". Netherlands. https://doi.org/10.1016/j.celrep.2016.04.038.
@article{osti_1325319,
title = {A Therapeutic Antibody for Cancer, Derived from Single Human B Cells},
author = {Bushey, Ryan T. and Moody, M. Anthony and Nicely, Nathan L. and Haynes, Barton F. and Alam, S. Munir and Keir, Stephen T. and Bentley, Rex C. and Roy Choudhury, Kingshuk and Gottlin, Elizabeth B. and Campa, Michael J. and Liao, Hua-Xin and Patz, Jr., Edward F.},
abstractNote = {Some patients with cancer never develop metastasis, and their host response might provide cues for innovative treatment strategies. We previously reported an association between autoantibodies against complement factor H (CFH) and early-stage lung cancer. CFH prevents complement-mediated cytotoxicity (CDC) by inhibiting formation of cell-lytic membrane attack complexes on self-surfaces. In an effort to translate these findings into a biologic therapy for cancer, we isolated and expressed DNA sequences encoding high-affinity human CFH antibodies directly from single, sorted B cells obtained from patients with the antibody. The co-crystal structure of a CFH antibody-target complex shows a conformational change in the target relative to the native structure. This recombinant CFH antibody causes complement activation and release of anaphylatoxins, promotes CDC of tumor cell lines, and inhibits tumor growth in vivo. The isolation of anti-tumor antibodies derived from single human B cells represents an alternative paradigm in antibody drug discovery.},
doi = {10.1016/j.celrep.2016.04.038},
journal = {Cell Reports},
number = 7,
volume = 15,
place = {Netherlands},
year = {Sun May 01 00:00:00 EDT 2016},
month = {Sun May 01 00:00:00 EDT 2016}
}
https://doi.org/10.1016/j.celrep.2016.04.038
Web of Science
Works referenced in this record:
Structural Analysis of the C-Terminal Region (Modules 18–20) of Complement Regulator Factor H (FH)
journal, February 2012
- Morgan, Hugh P.; Mertens, Haydyn D. T.; Guariento, Mara
- PLoS ONE, Vol. 7, Issue 2
Functional Anatomy of Complement Factor H
journal, May 2013
- Makou, Elisavet; Herbert, Andrew P.; Barlow, Paul N.
- Biochemistry, Vol. 52, Issue 23
Complement control protein factor H: The good, the bad, and the inadequate
journal, August 2010
- Ferreira, Viviana P.; Pangburn, Michael K.; Cortés, Claudio
- Molecular Immunology, Vol. 47, Issue 13
Complement Is a Central Mediator of Radiotherapy-Induced Tumor-Specific Immunity and Clinical Response
journal, April 2015
- Surace, Laura; Lysenko, Veronika; Fontana, Andrea Orlando
- Immunity, Vol. 42, Issue 4
Iterative model building, structure refinement and density modification with the PHENIX AutoBuild wizard
journal, December 2007
- Terwilliger, Thomas C.; Grosse-Kunstleve, Ralf W.; Afonine, Pavel V.
- Acta Crystallographica Section D Biological Crystallography, Vol. 64, Issue 1
Crystal Structure of the Calcium-stabilized Human Factor IX Gla Domain Bound to a Conformation-specific Anti-factor IX Antibody
journal, April 2004
- Huang, Mingdong; Furie, Barbara C.; Furie, Bruce
- Journal of Biological Chemistry, Vol. 279, Issue 14
Complement Factor H Antibodies from Lung Cancer Patients Induce Complement-Dependent Lysis of Tumor Cells, Suggesting a Novel Immunotherapeutic Strategy
journal, July 2015
- Campa, Michael J.; Gottlin, Elizabeth B.; Bushey, Ryan T.
- Cancer Immunology Research, Vol. 3, Issue 12
Features and development of Coot
journal, March 2010
- Emsley, P.; Lohkamp, B.; Scott, W. G.
- Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 4
Complement Factor H-Antibody–Associated Hemolytic Uremic Syndrome: Pathogenesis, Clinical Presentation, and Treatment
journal, May 2014
- Hofer, Johannes; Giner, Thomas; Józsi, Mihály
- Seminars in Thrombosis and Hemostasis, Vol. 40, Issue 04
Complement Factor H Autoantibodies Are Associated with Early Stage NSCLC
journal, June 2010
- Amornsiripanitch, Nita; Hong, Shaolin; Campa, Michael J.
- Clinical Cancer Research, Vol. 16, Issue 12
Structure validation by Cα geometry: ϕ,ψ and Cβ deviation
journal, January 2003
- Lovell, Simon C.; Davis, Ian W.; Arendall, W. Bryan
- Proteins: Structure, Function, and Bioinformatics, Vol. 50, Issue 3
PHENIX: a comprehensive Python-based system for macromolecular structure solution
journal, January 2010
- Adams, Paul D.; Afonine, Pavel V.; Bunkóczi, Gábor
- Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2, p. 213-221
Exceptional Resistance of Human H2 Glioblastoma Cells to Complement-Mediated Killing by Expression and Utilization of Factor H and Factor H-Like Protein 1
journal, June 2000
- Junnikkala, S.; Jokiranta, T. S.; Friese, M. A.
- The Journal of Immunology, Vol. 164, Issue 11
Sequence of a human immunoglobulin gamma 3 heavy chain constant region gene: comparison with the other human C γ genes
journal, January 1986
- Huck, S.; Fort, P.; Crawford, D. H.
- Nucleic Acids Research, Vol. 14, Issue 4
Reconstructing a B-Cell Clonal Lineage. II. Mutation, Selection, and Affinity Maturation
journal, April 2014
- Kepler, Thomas B.; Munshaw, Supriya; Wiehe, Kevin
- Frontiers in Immunology, Vol. 5
Structural and Functional Characterization of the Product of Disease-Related Factor H Gene Conversion
journal, February 2012
- Herbert, Andrew P.; Kavanagh, David; Johansson, Conny
- Biochemistry, Vol. 51, Issue 9
Reconstructing a B-cell clonal lineage. I. Statistical inference of unobserved ancestors
journal, January 2013
- Kepler, Thomas B.
- F1000Research, Vol. 2
Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated
journal, October 2011
- Liao, Hua-Xin; Chen, Xi; Munshaw, Supriya
- The Journal of Experimental Medicine, Vol. 208, Issue 11
Cytolysis of nucleated cells by complement: cell death displays multi-hit characteristics.
journal, June 1983
- Koski, C. L.; Ramm, L. E.; Hammer, C. H.
- Proceedings of the National Academy of Sciences, Vol. 80, Issue 12
The possible role of factor H in colon cancer resistance to complement attack
journal, January 2008
- Wilczek, Ewa; Rzepko, Robert; Nowis, Dominika
- International Journal of Cancer, Vol. 122, Issue 9
The complete amino acid sequence of a mouse ϰ light chain
journal, June 1972
- Svasti, J.; Milstein, C.
- Biochemical Journal, Vol. 128, Issue 2
Crystal structure of a non-neutralizing antibody to the HIV-1 gp41 membrane-proximal external region
journal, November 2010
- Nicely, Nathan I.; Dennison, S. Moses; Spicer, Leonard
- Nature Structural & Molecular Biology, Vol. 17, Issue 12
High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies
journal, June 2009
- Liao, Hua-Xin; Levesque, Marc C.; Nagel, Ashleigh
- Journal of Virological Methods, Vol. 158, Issue 1-2
Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis; a comparison with normal human respiratory epitheliumin vitro, and an insight into mechanism(s) of resistance
journal, December 2001
- Varsano, S.; Rashkovsky, L.; Shapiro, H.
- Clinical and Experimental Immunology, Vol. 113, Issue 2, p. 173-182
The role of the anaphylatoxins in health and disease
journal, September 2009
- Klos, Andreas; Tenner, Andrea J.; Johswich, Kay-Ole
- Molecular Immunology, Vol. 46, Issue 14
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
journal, April 2013
- Liao, Hua-Xin; Lynch, Rebecca; Zhou, Tongqing
- Nature, Vol. 496, Issue 7446
Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement
journal, February 2011
- Kajander, T.; Lehtinen, M. J.; Hyvarinen, S.
- Proceedings of the National Academy of Sciences, Vol. 108, Issue 7
Structural basis for engagement by complement factor H of C3b on a self surface
journal, February 2011
- Morgan, Hugh P.; Schmidt, Christoph Q.; Guariento, Mara
- Nature Structural & Molecular Biology, Vol. 18, Issue 4
Crystal structure of human germline antibody 3-23/B3
journal, July 2011
- Malia, Thomas J.; Obmolova, Galina; Almagro, Juan Carlos
- Molecular Immunology, Vol. 48, Issue 12-13
[20] Processing of X-ray diffraction data collected in oscillation mode
book, January 1997
- Otwinowski, Zbyszek; Minor, Wladek
- Macromolecular Crystallography Part A, 307-326
Down-Regulation of Human Complement Factor H Sensitizes Non-Small Cell Lung Cancer Cells to Complement Attack and Reduces In Vivo Tumor Growth
journal, April 2007
- Ajona, Daniel; Hsu, Yi-Fan; Corrales, Leticia
- The Journal of Immunology, Vol. 178, Issue 9
Isolation of a Human Anti-HIV gp41 Membrane Proximal Region Neutralizing Antibody by Antigen-Specific Single B Cell Sorting
journal, September 2011
- Morris, Lynn; Chen, Xi; Alam, Munir
- PLoS ONE, Vol. 6, Issue 9